|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,825.00 JPY | +0.55% |
|
+3.15% | +3.28% |
| 29/12 | Japan's Nikkei falls as tech stocks track Wall Street lower | RE |
| 18/12 | Italy raids illegal tobacco factory, seizes 27 tonnes of cigarettes | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.02 | 5.45 | 6.46 | 5.83 | 2.41 | |||||
Return on Total Capital | 7.41 | 8.19 | 9.5 | 8.37 | 3.55 | |||||
Return On Equity % | 11.68 | 12.4 | 13.66 | 12.89 | 4.71 | |||||
Return on Common Equity | 11.97 | 12.7 | 13.94 | 13.09 | 4.72 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 57.09 | 58.84 | 58.95 | 56.85 | 55.32 | |||||
SG&A Margin | 28.65 | 30.74 | 28.46 | 28.2 | 40.63 | |||||
EBITDA Margin % | 28.98 | 28.99 | 31.47 | 29.03 | 15.29 | |||||
EBITA Margin % | 24.14 | 20.94 | 23.95 | 22.71 | 9.58 | |||||
EBIT Margin % | 20.97 | 20.94 | 23.95 | 22.71 | 9.58 | |||||
Income From Continuing Operations Margin % | 14.91 | 14.63 | 16.71 | 17.08 | 5.8 | |||||
Net Income Margin % | 14.83 | 14.56 | 16.66 | 16.98 | 5.69 | |||||
Net Avail. For Common Margin % | 14.83 | 14.56 | 16.66 | 16.98 | 5.69 | |||||
Normalized Net Income Margin | 11.74 | 12.41 | 13.69 | 13.15 | 4.36 | |||||
Levered Free Cash Flow Margin | 19.75 | 17.77 | 10.99 | 12.31 | 6.15 | |||||
Unlevered Free Cash Flow Margin | 20.43 | 18.39 | 11.62 | 12.94 | 7 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.42 | 0.43 | 0.41 | 0.4 | |||||
Fixed Assets Turnover | 2.68 | 3.07 | 3.47 | 3.56 | 3.64 | |||||
Receivables Turnover (Average Receivables) | 5.02 | 5.41 | 5.69 | 5.61 | 5.7 | |||||
Inventory Turnover (Average Inventory) | 1.6 | 1.74 | 1.74 | 1.61 | 1.57 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.51 | 1.55 | 1.74 | 1.69 | 1.67 | |||||
Quick Ratio | 0.74 | 0.8 | 0.87 | 0.83 | 0.77 | |||||
Operating Cash Flow to Current Liabilities | 0.39 | 0.4 | 0.31 | 0.29 | 0.29 | |||||
Days Sales Outstanding (Average Receivables) | 72.87 | 67.46 | 64.12 | 65.04 | 64.16 | |||||
Days Outstanding Inventory (Average Inventory) | 228.94 | 210.36 | 209.95 | 226.94 | 232.72 | |||||
Average Days Payable Outstanding | 99.34 | 146.98 | 163.97 | 151.28 | 149.58 | |||||
Cash Conversion Cycle (Average Days) | 202.47 | 130.84 | 110.1 | 140.7 | 147.3 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 39.45 | 31.83 | 26.5 | 29.2 | 44.87 | |||||
Total Debt / Total Capital | 28.29 | 24.14 | 20.95 | 22.6 | 30.97 | |||||
LT Debt/Equity | 33.34 | 26.88 | 22.7 | 23.23 | 40.22 | |||||
Long-Term Debt / Total Capital | 23.91 | 20.39 | 17.95 | 17.98 | 27.77 | |||||
Total Liabilities / Total Assets | 51.69 | 50.02 | 44.77 | 46.27 | 54.02 | |||||
EBIT / Interest Expense | 19.47 | 21.12 | 23.56 | 22.64 | 7.1 | |||||
EBITDA / Interest Expense | 27.79 | 29.23 | 30.95 | 28.95 | 11.34 | |||||
(EBITDA - Capex) / Interest Expense | 24 | 25.49 | 27.94 | 25.62 | 8.33 | |||||
Total Debt / EBITDA | 1.64 | 1.36 | 1.15 | 1.38 | 3.59 | |||||
Net Debt / EBITDA | 0.75 | 0.29 | 0.11 | 0.12 | 1.33 | |||||
Total Debt / (EBITDA - Capex) | 1.9 | 1.56 | 1.27 | 1.56 | 4.88 | |||||
Net Debt / (EBITDA - Capex) | 0.86 | 0.34 | 0.12 | 0.14 | 1.82 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.82 | 11.1 | 14.32 | 6.89 | 10.86 | |||||
Gross Profit, 1 Yr. Growth % | -3.14 | 14.52 | 14.54 | 3.08 | 7.88 | |||||
EBITDA, 1 Yr. Growth % | -5.41 | 11.1 | 24.11 | -1.38 | -41.61 | |||||
EBITA, 1 Yr. Growth % | -6.76 | -3.61 | 30.78 | 1.33 | -53.23 | |||||
EBIT, 1 Yr. Growth % | -6.42 | 10.95 | 30.78 | 1.33 | -53.23 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -13.71 | 9.02 | 30.57 | 9.26 | -62.38 | |||||
Net Income, 1 Yr. Growth % | -10.9 | 9.1 | 30.79 | 8.94 | -62.84 | |||||
Normalized Net Income, 1 Yr. Growth % | -5.95 | 17.38 | 26.17 | 2.68 | -63.28 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -10.76 | 9.08 | 30.77 | 8.93 | -62.84 | |||||
Accounts Receivable, 1 Yr. Growth % | -6.41 | 13.35 | 4.52 | 12.17 | 6.29 | |||||
Inventory, 1 Yr. Growth % | -7.53 | 4.34 | 22.86 | 20.34 | 14.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.47 | -0.45 | 2.66 | 5.87 | 10.49 | |||||
Total Assets, 1 Yr. Growth % | -3.09 | 7.3 | 13.4 | 11.21 | 14.95 | |||||
Tangible Book Value, 1 Yr. Growth % | 13.73 | 76.57 | 92.21 | 18.73 | -63.65 | |||||
Common Equity, 1 Yr. Growth % | -5.25 | 11.35 | 26.03 | 8.18 | -1.66 | |||||
Cash From Operations, 1 Yr. Growth % | -3.81 | 15.21 | -19.22 | 17.2 | 11.11 | |||||
Capital Expenditures, 1 Yr. Growth % | -23.39 | 1.21 | -5.72 | 16.52 | 34.69 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 30.9 | -0.07 | -29.3 | 19.79 | -44.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 28.36 | 0 | -27.73 | 19 | -40.05 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | -9.09 | 34.29 | 3.19 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.82 | 3.37 | 12.7 | 10.55 | 8.86 | |||||
Gross Profit, 2 Yr. CAGR % | -3.51 | 5.32 | 14.53 | 8.66 | 5.45 | |||||
EBITDA, 2 Yr. CAGR % | -8.2 | 2.51 | 17.43 | 10.63 | -24.12 | |||||
EBITA, 2 Yr. CAGR % | -9.95 | -5.2 | 12.28 | 15.12 | -31.16 | |||||
EBIT, 2 Yr. CAGR % | -11.57 | 1.9 | 20.46 | 15.12 | -31.16 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -10.26 | -3.01 | 19.31 | 19.44 | -35.88 | |||||
Net Income, 2 Yr. CAGR % | -10.31 | -1.4 | 19.46 | 19.37 | -36.37 | |||||
Normalized Net Income, 2 Yr. CAGR % | -13.77 | 5.06 | 21.69 | 13.82 | -38.59 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -9.87 | -1.33 | 19.44 | 19.35 | -36.38 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.08 | 3 | 8.85 | 8.28 | 9.19 | |||||
Inventory, 2 Yr. CAGR % | -8.82 | -1.77 | 13.22 | 21.59 | 17.62 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.03 | -3 | 1.09 | 4.25 | 8.16 | |||||
Total Assets, 2 Yr. CAGR % | -0.74 | 1.97 | 10.31 | 12.3 | 13.06 | |||||
Tangible Book Value, 2 Yr. CAGR % | 44.83 | 41.71 | 84.23 | 51.07 | -34.31 | |||||
Common Equity, 2 Yr. CAGR % | -2.07 | 2.72 | 18.46 | 16.76 | 3.14 | |||||
Cash From Operations, 2 Yr. CAGR % | 6.14 | 5.27 | -3.53 | -2.7 | 14.11 | |||||
Capital Expenditures, 2 Yr. CAGR % | -21.54 | -11.94 | -2.32 | 4.81 | 25.28 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 9.58 | 9.11 | -15.95 | -7.97 | -18.53 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.66 | 8.34 | -14.99 | -7.26 | -15.53 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.32 | -4.65 | 10.49 | 17.72 | 1.58 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.74 | 1.61 | 6.9 | 10.73 | 10.65 | |||||
Gross Profit, 3 Yr. CAGR % | -2.68 | 2.16 | 8.31 | 10.58 | 8.4 | |||||
EBITDA, 3 Yr. CAGR % | -2.89 | -0.32 | 9.26 | 10.79 | -10.6 | |||||
EBITA, 3 Yr. CAGR % | -4.65 | -2.28 | 5.53 | 8.5 | -14.74 | |||||
EBIT, 3 Yr. CAGR % | -6.09 | -2.28 | 10.74 | 13.71 | -14.74 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -7.69 | -4.24 | 7.09 | 15.86 | -18.73 | |||||
Net Income, 3 Yr. CAGR % | -7.53 | -4.26 | 8.34 | 15.84 | -19.1 | |||||
Normalized Net Income, 3 Yr. CAGR % | -8.31 | -1.93 | 11.67 | 14.99 | -21.93 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -7.23 | -3.95 | 8.38 | 15.83 | -19.11 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.07 | -0 | 3.5 | 9.94 | 7.61 | |||||
Inventory, 3 Yr. CAGR % | -4.15 | -4.63 | 5.83 | 15.54 | 19.34 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.61 | -0.13 | -1.15 | 2.66 | 6.29 | |||||
Total Assets, 3 Yr. CAGR % | 1.01 | 1.87 | 5.65 | 10.61 | 13.18 | |||||
Tangible Book Value, 3 Yr. CAGR % | -13.89 | 54.72 | 56.87 | 59.13 | -6.04 | |||||
Common Equity, 3 Yr. CAGR % | -2.97 | 2.21 | 9.96 | 14.93 | 10.27 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.43 | 9.08 | -3.62 | 2.94 | 1.7 | |||||
Capital Expenditures, 3 Yr. CAGR % | -11.65 | -14.59 | -9.92 | 3.6 | 13.95 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 38.2 | 10.9 | -5.58 | -5.41 | -22.29 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 37.66 | 10.95 | -5.34 | -4.9 | -19.81 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.23 | -2.27 | 6.88 | 8 | 11.49 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -1.47 | 1.64 | 4.43 | 5.1 | 7.68 | |||||
Gross Profit, 5 Yr. CAGR % | -2.17 | 1.48 | 3.87 | 4.71 | 7.15 | |||||
EBITDA, 5 Yr. CAGR % | -3.42 | 0.36 | 4.78 | 3.93 | -5.57 | |||||
EBITA, 5 Yr. CAGR % | -4.34 | -3.57 | 1.79 | 4.34 | -11.04 | |||||
EBIT, 5 Yr. CAGR % | -5.92 | -1.83 | 3.75 | 4.34 | -8.44 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -4.98 | -4.39 | 2.28 | 4.61 | -12.77 | |||||
Net Income, 5 Yr. CAGR % | -8.57 | -4.3 | 2.44 | 4.57 | -12.44 | |||||
Normalized Net Income, 5 Yr. CAGR % | -8.06 | -2.45 | 2.68 | 4.09 | -12.09 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.64 | -4.12 | 2.63 | 4.77 | -12.42 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.59 | 3.46 | 2.79 | 3.23 | 5.74 | |||||
Inventory, 5 Yr. CAGR % | -0.87 | 0.15 | 2.45 | 5.1 | 10.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.17 | 2.11 | 0.8 | 1.6 | 2.48 | |||||
Total Assets, 5 Yr. CAGR % | 3.38 | 4.01 | 4.63 | 5.92 | 8.55 | |||||
Tangible Book Value, 5 Yr. CAGR % | -18.38 | 0.51 | 16.73 | 53.25 | 10.74 | |||||
Common Equity, 5 Yr. CAGR % | 0.57 | 2.72 | 5.09 | 7.8 | 7.18 | |||||
Cash From Operations, 5 Yr. CAGR % | 2.1 | 9.73 | 2.91 | 4.21 | 3.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | -6.12 | -3.1 | -8.03 | -7.3 | 2.79 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.48 | 13.26 | 13.28 | 2.93 | -10.99 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 2.04 | 13.49 | 13.52 | 3.27 | -9.55 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.47 | 1.49 | 6.07 | 5.28 | 4.73 |
- Stock Market
- Equities
- 2914 Stock
- Financials Japan Tobacco Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















